Genetics of Crohn disease, an archetypal inflammatory barrier disease

Chronic inflammatory disorders such as Crohn disease, atopic eczema, asthma and psoriasis are triggered by hitherto unknown environmental factors that function on the background of some polygenic susceptibility. Recent technological advances have allowed us to unravel the genetic aetiology of these and other complex diseases. Using Crohn disease as an example, we show how the discovery of susceptibility genes furthers our understanding of the underlying disease mechanisms and how it will, ultimately, give rise to new therapeutic developments. The long-term goal of such endeavours is to develop targeted prophylactic strategies. These will probably target the molecular interaction on the mucosal surface between the products of the genome and the microbial metagenome of a patient.

[1]  J. Cavanaugh,et al.  International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. , 2001, American journal of human genetics.

[2]  G. Churchill,et al.  Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice. , 1999, Genomics.

[3]  Thomas Lengauer,et al.  Structural localization of disease‐associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2 , 2003, FEBS letters.

[4]  C. Elson,et al.  Heritable Susceptibility for Colitis in Mice Induced by IL‐10 Deficiency , 2000, Inflammatory bowel diseases.

[5]  Alastair Forbes,et al.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. , 2002, Gastroenterology.

[6]  Howard C. Berg,et al.  Genetic analysis , 1957, Nature Biotechnology.

[7]  T. Sørensen,et al.  Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. , 1993, BMJ.

[8]  H. Aihara,et al.  Mapping of a disease susceptibility locus in chromosome 6p in Japanese patients with ulcerative colitis , 2004, Genes and Immunity.

[9]  Bill Newman,et al.  Functional variants of OCTN cation transporter genes are associated with Crohn disease , 2004, Nature Genetics.

[10]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[11]  Richard Beasley,et al.  Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC , 1998, The Lancet.

[12]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[13]  Luc J. Smink,et al.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease , 2003, Nature.

[14]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[15]  S. Targan,et al.  A genome-wide search identifies potential new susceptibility loci for Crohn's disease. , 1999, Inflammatory bowel diseases.

[16]  M. Parkes,et al.  Contribution of the IL‐2 and IL‐10 genes to inflammatory bowel disease (IBD) susceptibility , 1998, Clinical and experimental immunology.

[17]  Jean Weissenbach,et al.  Mapping of a susceptibility locus for Crohn's disease on chromosome 16 , 1996, Nature.

[18]  S. Fisher,et al.  Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. , 2003, American journal of human genetics.

[19]  R Balfour Sartor,et al.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.

[20]  P. Rosenstiel,et al.  TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells ☆ ☆☆ ★ ★★ ♢ , 2003 .

[21]  S. Fanaro,et al.  Intestinal microflora in early infancy: composition and development , 2003, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[22]  D. Podolsky,et al.  CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. , 2003, Gastroenterology.

[23]  Michael Karin,et al.  Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing , 2005, Science.

[24]  J. Ting,et al.  CATERPILLER: a novel gene family important in immunity, cell death, and diseases. , 2005, Annual review of immunology.

[25]  W. Kruis Review article: antibiotics and probiotics in inflammatory bowel disease. , 2004, Alimentary pharmacology & therapeutics.

[26]  B. Xia,et al.  NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. , 2004, World journal of gastroenterology.

[27]  E. Koonin,et al.  STAND, a class of P-loop NTPases including animal and plant regulators of programmed cell death: multiple, complex domain architectures, unusual phyletic patterns, and evolution by horizontal gene transfer. , 2004, Journal of molecular biology.

[28]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.

[29]  C. Shin,et al.  Cell signalling and the control of pre-mRNA splicing , 2004, Nature Reviews Molecular Cell Biology.

[30]  E. Lindberg,et al.  Different intestinal permeability patterns in relatives and spouses of patients with Crohn’s disease: an inherited defect in mucosal defence? , 1999, Gut.

[31]  T. Hibi,et al.  Lack of common NOD2 variants in Japanese patients with Crohn's disease. , 2002, Gastroenterology.

[32]  M. Shriver,et al.  Interrogating a high-density SNP map for signatures of natural selection. , 2002, Genome research.

[33]  M. Hornef,et al.  Toll-like Receptor 4 Resides in the Golgi Apparatus and Colocalizes with Internalized Lipopolysaccharide in Intestinal Epithelial Cells , 2002, The Journal of experimental medicine.

[34]  L. Cardon,et al.  Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. , 2002 .

[35]  K. Huse,et al.  Sarcoidosis is associated with a truncating splice site mutation in BTNL2 , 2005, Nature Genetics.

[36]  Judy H. Cho,et al.  [Letters to Nature] , 1975, Nature.

[37]  L. Cardon,et al.  Fine mapping of the IBD1 locus did not identify Crohn disease-associated NOD2 variants: implications for complex disease genetics. , 2002, American journal of medical genetics.

[38]  J. Hampe,et al.  Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure , 2003, International Journal of Colorectal Disease.

[39]  M. Daly,et al.  Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Daly,et al.  Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies , 2001, Gut.

[41]  T. Sørensen,et al.  Familial occurrence of inflammatory bowel disease. , 1991, The New England journal of medicine.

[42]  R. Pounder,et al.  Genetics versus environment in inflammatory bowel disease: results of a British twin study , 1996, BMJ.

[43]  J. Bach,et al.  The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.

[44]  Richard A. Flavell,et al.  Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.

[45]  J. Valentine,et al.  Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease , 2004, The Lancet.

[46]  E S Lander,et al.  Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. , 2000, American journal of human genetics.

[47]  Thomas Lengauer,et al.  Genetic variation in DLG5 is associated with inflammatory bowel disease , 2004, Nature Genetics.

[48]  S. Dinesh-Kumar,et al.  Alternatively spliced N resistance gene transcripts: their possible role in tobacco mosaic virus resistance. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  S. Salminen,et al.  Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial , 2001, The Lancet.

[50]  J. Pritchard,et al.  The allelic architecture of human disease genes: common disease-common variant...or not? , 2002, Human molecular genetics.

[51]  M. Daly,et al.  IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. , 2003, American journal of human genetics.

[52]  N E Morton,et al.  Tests and estimates of allelic association in complex inheritance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Pritchard,et al.  Use of unlinked genetic markers to detect population stratification in association studies. , 1999, American journal of human genetics.

[54]  M. Abreu,et al.  Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide1 , 2001, The Journal of Immunology.

[55]  V. Binder Epidemiology of IBD during the twentieth century: an integrated view. , 2004, Best practice & research. Clinical gastroenterology.

[56]  J. Ting,et al.  Cutting Edge: CATERPILLER: A Large Family of Mammalian Genes Containing CARD, Pyrin, Nucleotide-Binding, and Leucine-Rich Repeat Domains1 , 2002, The Journal of Immunology.

[57]  C. Jobin Intestinal epithelial cells and innate immunity in the intestine: is CARD15/Nod2 another player? , 2003, Gastroenterology.

[58]  H. Lochs,et al.  Intestinal permeability and the prediction of relapse in Crohri's disease , 1993, The Lancet.

[59]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[60]  J. Rotter,et al.  Intestinal permeability in patients with Crohn's disease and their healthy relatives. , 1989, Gastroenterology.

[61]  F. Majewski,et al.  The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. , 1989, American journal of medical genetics.

[62]  V. Sperandio,et al.  Cell-to-cell signaling in intestinal pathogens. , 2004, Current issues in intestinal microbiology.

[63]  J. Sundberg,et al.  A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Yusuke Nakamura,et al.  Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease , 2004, Journal of Human Genetics.

[65]  A. Macpherson,et al.  Interactions between commensal intestinal bacteria and the immune system , 2004, Nature Reviews Immunology.

[66]  B. Müller-Myhsok,et al.  Results from a genome-wide search for predisposing genes in sarcoidosis. , 2001, American journal of respiratory and critical care medicine.

[67]  A. Peña,et al.  Environmental risk factors in inflammatory bowel disease. , 1996, Hepato-gastroenterology.

[68]  F. Rocca,et al.  Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group). , 1992, Gastroenterology.

[69]  L. Cardon,et al.  A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. , 1999, American journal of human genetics.

[70]  M. Loreau,et al.  Biodiversity and ecosystem productivity in a fluctuating environment: the insurance hypothesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[71]  J. Trent,et al.  Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[72]  S. Fisher,et al.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.

[73]  J. Sundberg,et al.  Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[74]  Yi Xing,et al.  Assessing the impact of alternative splicing on domain interactions in the human proteome. , 2004, Journal of proteome research.

[75]  L. Newman,et al.  Medical progress : Sarcoidosis , 1997 .

[76]  Rolf Backofen,et al.  Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity , 2004, Nature Genetics.

[77]  Sinead B. O'Leary,et al.  Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease , 2001, Nature Genetics.

[78]  J. Weber,et al.  Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[79]  G. Oppenheimer,et al.  Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer. , 1984, JAMA.

[80]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[81]  D. Coggon,et al.  Inflammatory bowel disease and domestic hygiene in infancy , 1994, The Lancet.

[82]  T. Ahmad,et al.  Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. , 2003, American journal of human genetics.

[83]  J. Gordon,et al.  Commensal Host-Bacterial Relationships in the Gut , 2001, Science.

[84]  S. Dinesh-Kumar,et al.  Structure-function analysis of the tobacco mosaic virus resistance gene N. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[85]  N. Wood,et al.  Genetic association studies , 2001, Neurology.

[86]  K. Huse,et al.  Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations , 2003, European Journal of Human Genetics.

[87]  W. Walker Role of nutrients and bacterial colonization in the development of intestinal host defense. , 2000, Journal of pediatric gastroenterology and nutrition.

[88]  K. Welsh,et al.  Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. , 2001, American journal of respiratory cell and molecular biology.

[89]  M Schwab,et al.  NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression , 2004, Gut.

[90]  V. Godfrey,et al.  IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[91]  E. Jabs,et al.  American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. , 1998, Gastroenterology.

[92]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[93]  W. Walker,et al.  Protective nutrients and bacterial colonization in the immature human gut. , 1999, Advances in pediatrics.

[94]  J. Mcghee,et al.  Murine bone marrow IgA responses to orally administered sheep erythrocytes. , 1986, Journal of immunology.

[95]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Genetic Analysis , 1989, Science.

[96]  D. Gudbjartsson,et al.  Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives? , 2003, Gastroenterology.

[97]  J. Hampe,et al.  Patterns of linkage disequilibrium in the MHC region on human chromosome 6p , 2004, Human Genetics.

[98]  E. Lindberg,et al.  Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. , 1988, Gut.

[99]  D. D. Jong,et al.  NOD 2 mediates anti-inflammatory signals induced byTLR 2 ligands : implications for Crohn ’ s disease , 2004 .

[100]  J. Hampe,et al.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.

[101]  N. Risch Searching for genetic determinants in the new millennium , 2000, Nature.

[102]  J. Ting,et al.  Cutting Edge: CIAS1/Cryopyrin/PYPAF1/NALP3/ CATERPILLER 1.1 Is an Inducible Inflammatory Mediator with NF-κB Suppressive Properties , 2003, The Journal of Immunology.

[103]  Toshihiro Tanaka The International HapMap Project , 2003, Nature.

[104]  A. Gewirtz Intestinal epithelial toll-like receptors: to protect. And serve? , 2003, Current pharmaceutical design.

[105]  L. Tsui,et al.  Identification of the cystic fibrosis gene: genetic analysis. , 1989, Science.

[106]  J. Terwilliger,et al.  Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 , 1996, Nature Genetics.

[107]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[108]  Daniel J Schaid,et al.  Genetic epidemiology and haplotypes , 2004, Genetic epidemiology.

[109]  J. Pritchard,et al.  Evidence for extensive transmission distortion in the human genome. , 2004, American journal of human genetics.

[110]  M. Daly,et al.  New Approaches to Gene Hunting in IBD , 2004, Inflammatory bowel diseases.

[111]  B. Franke,et al.  NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease , 2004, European journal of immunology.

[112]  K. Huse,et al.  Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[113]  J. Marshall,et al.  Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. , 2000, Gastroenterology.

[114]  N J Lynch,et al.  Linkage of inflammatory bowel disease to human chromosome 6p. , 1999, American journal of human genetics.

[115]  Thomas Lengauer,et al.  Disease-associated variants in PYPAF1 and NOD2 result in similar alterations of conserved sequence , 2003, Bioinform..

[116]  S. Cannon,et al.  Structural, expression, and evolutionary analysis of mouse CIAS1. , 2004, Gene.

[117]  W. Kruis,et al.  Antibiotics and probiotics in inflammatory bowel disease , 2004, Alimentary pharmacology & therapeutics.

[118]  L. Cardon,et al.  Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. , 1998, Gastroenterology.

[119]  J. Satsangi,et al.  The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease , 1994 .

[120]  M. Kagnoff,et al.  Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. , 1999, Journal of immunology.

[121]  D J Schaid,et al.  Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. , 1999, American journal of epidemiology.

[122]  S. Dinesh-Kumar,et al.  Structure – function analysis of the tobacco mosaic virus resistance gene , 2000 .

[123]  M. Daly,et al.  Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. , 2004, Human molecular genetics.

[124]  Julian P T Higgins,et al.  Obstacles and opportunities in meta-analysis of genetic association studies , 2005, Genetics in Medicine.

[125]  C. V. van Duijn,et al.  Genetic association studies: genes in search of diseases. , 2002, Neurology.

[126]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[127]  Masaru Mitsushima,et al.  Interaction of lp-dlg/KIAA0583, a Membrane-associated Guanylate Kinase Family Protein, with Vinexin and β-Catenin at Sites of Cell-Cell Contact* , 2003, Journal of Biological Chemistry.

[128]  M. Iannuzzi,et al.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. , 2003, American journal of human genetics.

[129]  J. Nadeau,et al.  Finding Genes That Underlie Complex Traits , 2002, Science.

[130]  K. Ewe,et al.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) , 1995, Clinical and experimental immunology.

[131]  S. Hampson Randomised, placebo-controlled trial , 2002 .

[132]  L. Cardon,et al.  The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants. , 2003, Human molecular genetics.

[133]  Genes in search of diseases , 2001 .

[134]  H. Deng,et al.  Re: "Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions". , 2000, American journal of epidemiology.

[135]  K. McCann The diversity–stability debate , 2000, Nature.

[136]  Ruth E. Hartley,et al.  An integrated view. , 1973 .

[137]  D. Podolsky,et al.  Lipopolysaccharide Activates Distinct Signaling Pathways in Intestinal Epithelial Cell Lines Expressing Toll-Like Receptors1 , 2000, The Journal of Immunology.